Methylated CpG polynucleotide

Details Methylated CpG polynucleotide Methylated CpG polynucleotide

2011-01-18

2011-01-18

Minnifield, N. M (Department: 1645)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

07871984

ABSTRACT:
It is an object of the present invention to provide a polynucleotide, which can effectively suppress the immunoreactivity caused by DNA having a CpG motif and which can be used for preventing and/or treating immune-mediated diseases such as arthritis. The present invention provides a polynucleotide comprising a CpG motif wherein guanine is methylated, and a pharmaceutical composition comprising the above-mentioned polynucleotide.

REFERENCES:
patent: 6579860 (2003-06-01), Koike et al.
patent: 6653292 (2003-11-01), Krieg et al.
patent: 6949520 (2005-09-01), Hartmann et al.
patent: 2004/0097465 (2004-05-01), Asari et al.
patent: 2004/0248834 (2004-12-01), Klinman et al.
patent: 2005/0169888 (2005-08-01), Hartmann et al.
patent: 2006/0074039 (2006-04-01), Klinman et al.
patent: 2002-521489 (2002-07-01), None
patent: 2003-510290 (2003-03-01), None
patent: WO 98/01880 (1998-05-01), None
patent: WO/98/18810 (1998-05-01), None
patent: 00/06588 (2000-02-01), None
patent: 00/38693 (2000-06-01), None
patent: 01/22990 (2001-04-01), None
patent: WO/01/48245 (2001-07-01), None
patent: 01/75092 (2001-10-01), None
patent: 02/074318 (2002-09-01), None
patent: 03/027313 (2003-04-01), None
Infante-Duarte et al., Thl/Th2 balance in infection. Springer Seminars in Immunopathology, 1999, 21: 317-338.
Katoaka et al (Jpn. J. Cancer Res. 1992 vol. 83 pp. 244-247.
Chu et al 1997 CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (TH1) Immuntiy pp. 1623-1630.
Weiner et al 1997 Proc. Natl. Acad. Sci. USA vol. 94 pp. 10833-10837.
Sugiyama et al 1996 Nucleic Acids Research vol. 24 No. 7 pp. 1272-1278.
Zharkov et al 2000 vol. 275 No. 37 pp. 28607-28617.
Gaffney et al 1984 Biochemistry vol. 23 pp. 5686-5691.
Churchwell et al 2006 Journal of Chromatography pp. 60-66.
Kalnik et al., “O6-Ethylguanine Carcinogenic Lesions in DNA: An NMR Study of O6etG•C Pairing in Dodecanucleotide Duplexes”, Biochemistry, vol. 28 (1989), pp. 6182-6192.
Kawai et al., “Intrastrand 2′β Hydrogen Abstraction of 5′-Adjacent Deoxyguanosine by Deoxyuridin-5-yl in Z-form DNA”, Tetrahedron Letters, vol. 40 (1999), pp. 2589-2592.
Lee et al., “DNA Microstructural Requirements for Neocarzinostatin Chromophore-induced Direct Strand Cleavage”, Nucleic Acids Research, vol. 17, No. 14 (1989), pp. 5809-5825.
Zhao et al., “Site of Chemical Modifications in CpG Containing Phosphorothioate Oligodeoxynucleotide Modulates Its Immunostimulatory Activity”, Bioorganic & Medicinal Chemistry Letters, vol. 9 (1999), pp. 3453-3458.
Sato et al., “Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization”, Science, vol. 273 (1996), pp. 352-354.
Krieg et al. “CpG Motifs in Bacterial DNA Trigger Direct B-cell Activation”, Nature, vol. 374 (1995), pp. 546-549.
Miyata et al., “Unmethylated Oligo-DNA Containing CpG Motifs Aggravates Collagen-Induced Athritis in Mice”, Athritis & Rheumatism, vol. 43, No. 11 (2000), pp. 2578-2582.
Leadbetter et al., “Chromatin-IgG Complexes Activate B-cells by Dual Engagement of IgM and Toll-like Receptors”, Nature, vol. 416 (2002), pp. 603-607.
Office Action issued in counterpart Japanese application, dated Sep. 14, 2010.

Affiliated with

Also associated with

Rating

Methylated CpG polynucleotide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methylated CpG polynucleotide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylated CpG polynucleotide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2682783